David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

30/06/2022 5 min
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

Listen "David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer"

Episode Synopsis

David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.Read the full article:Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in EuropeTell us what you thought about this episodeContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

More episodes of the podcast The Lancet Oncology in conversation with